Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Greetings, and welcome to the Aurora Cannabis Inc. second quarter 2025 results conference call. [Operator instructions] This ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Shares of Aurora Cannabis Inc. ACB slid 1.05% to $4.73 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to ...

Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ETCompany ParticipantsKevin Niland - Director, Strategic ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Q2 2025 Earnings Call Transcript November 6, 2024 Operator: Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Aurora Cannabis' profit rose in its fiscal second quarter thanks to a strong performance from its medical cannabis unit. For the three months ended Sept. 30, the Canadian medical cannabis company on ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

Aurora Cannabis (TSE:ACB) has released an update. Aurora Cannabis reported impressive fiscal 2025 second-quarter results, achieving a record ...